Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancerLuca Gianni, Giuseppe Viale, Giancarlo Bisagni et al.|npj Breast Cancer|2022Cited by 29